挑战肺栓塞——新一代口服抗凝血剂
@article{LCBL4753, author = {Barra Sérgio 和 Paiva Luís 和 Providência Rui }, title = {挑战肺栓塞——新一代口服抗凝血剂}, journal = {临床与病理杂志}, volume = {33}, number = {3}, year = {2014}, keywords = {}, abstract = {急性肺栓塞(pulmonary embolism,PE)是一种较常见的心血管急症,每年的发病率约为70/10万[1]。肺动脉血管床堵塞可能危及生命且存在可逆急性右心衰竭风险,这一点突出了早期准确诊断的必要性。初始治疗的主要目标是恢复堵塞的肺动脉血流并预防早期复发。}, url = {https://lcbl.amegroups.com/article/view/4753} }